Skip to main content
OpenTrials
Completed

NCT Number: NCT04896736

Multisite Tissue Oxygenation Guided Perioperative Care in Cardiac Surgery

The BOTTOMLINE-CS trial is an international, open, single-center, pragmatic, randomised controlled trial to investigate whether multisite tissue oxygen saturation monitoring-guided perioperative care reduces composite complications within 30 days of randomization in off-pump coronary artery bypass grafting.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Short title: BOTTOMLINE-CS trial Methodology: International, open, single-center, pragmatic, randomised controlled trial Research sites: Tianjin Chest Hospital Objectives: To investigate whether multisite tissue oxygen saturation monitoring-guided perioperative care reduces composite complications within 30 days of randomization in off-pump coronary artery bypass grafting Number of patients: 1960 patients (980 per arm, two arms) Inclusion criteria: Patients aged ≥ 60 years undergoing elective off-pump coronary artery bypass grafting Exclusion criteria: Patient refusal, clinician refusal, preoperative requirement of respiratory support (intubation, CPAP or BiPAP, or high-flow oxygen (>10 L/min)), preoperative requirement of external cardiac assist devices, emergent or urgent surgery, patients expected to die within 30 days, current participation in another clinical trial Statistical analysis: Analyses will be performed on a modified intention-to-treat basis including all randomized patients who had undergone the scheduled surgery and had the record of the primary outcome. Summary statistics for each group, treatment effects, 95% confidence intervals, and p values will be presented for primary and secondary outcomes, and process measures. The primary outcome is a composite of complications arising within 30 days from randomization and will be analyzed using a logistic regression model.

Proposed start date: May 1, 2021 (First patient to be recruited) Proposed end date: April 30, 2023 (Last patient to be recruited) Study duration: 48 months (Starting from the first patient recruitment, spanning patient recruitment, data analysis, and manuscript writing and submission)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged ≥ 60 years scheduled for elective off-pump CABG.

Exclusion criteria

  • Inability or refusal to provide consent of participation
  • Preoperative requirement of respiratory support (intubation, CPAP or BiPAP, or high-flow oxygen (>10 L/min))
  • Preoperative requirement of external cardiac assist device
  • Urgent or emergent surgery
  • Patients expected to die within 30 days of randomization

Treatment and study plan

Multisite tissue oxygenation-guided care

Other

The following intervention algorithm is intended to be used as a guidance only. We emphasize the different aspects that can cause changes in SctO2/SstO2 in a systematic approach. We avoid recommending a concrete drug and method of dosing for a specific condition.

Manage tissue perfusion Preload: overall picture including direct observation of the heart, findings of echocardiography, urine output, blood loss, labs results, HR, BP, PPV, SVV, fluid responsiveness (SV increase >/= 10% following 250 ml fluid bolus) Contractility: direct observation of the heart, findings of echocardiography Stroke volume and heart rate: important determinants of CO Systemic vascular resistance: important determinant of BP Regional vascular resistance: important determinant of tissue perfusion along with perfusion pressure Maintain autoregulation: normalize CO2, avoid potent vasodilators

Manage arterial blood oxygen content

Manage tissue metabolic activity

Usual Care

Other

Usual care in this study means the standard perioperative care. Patients who are meant to receive usual care will receive both cerebral and muscular tissue oxygen saturation monitoring; however, the monitor screen will be covered and the monitoring data will not be used to guide clinical care.

Primary outcomes

  1. Composite complication

    Time frame: from the day of surgery (i.e., day 0) until postoperative day 30 for a total of 31 days (individual components may vary)

    The primary outcome is a collapsed (one or more) composite of the following complications with a Clavien-Dindo grade II or greater arising within 30 days of randomization (randomization and surgery are performed on the same day). The patient is regarded as having the event of composite complications if any of the following complications occur (i.e., yes); otherwise, the patient is regarded as not having the event of composite complications. The percentage of patients having the event of composite complications will be used in the primary analysis.

    • Brain complications (delirium, cognition decline, stroke);
    • Cardiac complications (non-fatal cardiac arrest, myocardial injury, heart failure, new-onset symptomatic ventricular arrhythmia);
    • Respiratory failure;
    • Renal complications (AKI stages II and III);
    • Infectious complications;
    • Death.

Secondary outcomes

  1. Atrial fibrillation

    Time frame: from the day of surgery until postoperative day 30

    Atrial fibrillation

    A new diagnosis of AF per the current standard.

  2. Postoperative delirium

    Time frame: from postoperative day 1 throughout postoperative day 5

    Postoperative delirium (assessed using CAM-ICU Worksheet for patients in PACU and ICU, or CAM for patients on the floor). The validated Chinese version will be used for assessment.

    Delirium will be formally assessed as early in the morning as practical and early evening for the initial five postoperative days while patients remain hospitalized because this approach will detect nearly all postoperative delirium. Observed daytime delirium will be recorded and considered as an outcome. Delirium will not be evaluated the evening after surgery because confusion might result from residual anesthetic effects.

  3. Postoperative cognitive decline

    Time frame: Assessed before surgery, on postoperative day 5 and 30

    Postoperative cognitive decline (assessed using 30-points MoCA 7.1 version). The validated Chinese version will be used.

    MoCA evaluates multiple cognitive domains including executive function and is widely used. Validated versions of MoCA are available in many languages including Chinese and German. A decrease of ≥2 points is associated with cognitive decline based on formal neuropsychological testing and considered a clinically meaningful reduction.

  4. Length of hospital stay

    Time frame: from the day of surgery (day 0) until hospital discharge or until day 30, whichever occurs first

    Length of hospital stay in days

  5. Perioperative stroke

    Time frame: Stroke will be assessed from the day of surgery throughout postoperative day 30

    Any stroke per current clinical diagnostic criteria arising during surgery or after surgery until postoperative day 30.

  6. Cardiac complications (one component of the primary outcome)

    Time frame: from the day of surgery (i.e., day 0) until postoperative day 30 for a total of 31 days

    Cardiac complications include:

    • non-fatal cardiac arrest (An absence of cardiac rhythm or presence of chaotic rhythm requiring any component of basic or advanced cardiac life support.)
    • myocardial injury (Myocardial injury is defined as any myocardial infarction (i.e., 4th Universal Definition of myocardial infarction32), or any elevated troponin judged to be due to myocardial ischemia (i.e. without evidence of a non-ischemic etiology, e.g. chronic elevation, pulmonary embolism, sepsis, cardioversion, others) that occurred with the first 30 days after surgery.)
    • heart failure (per current standard diagnostic criteria.)
    • new-onset symptomatic ventricular arrhythmia (per current standard diagnostic criteria.)
  7. Respiratory failure (one component of the primary outcome)

    Time frame: from the day of surgery (i.e., day 0) until postoperative day 30 for a total of 31 days

    Respiratory failure is defined as the requirement of respiratory support (intubation, CPAP or BiPAP, or high-flow oxygen (>10 L/min)) for acute respiratory insufficiency for more than 6 hours after surgery.

  8. Renal complications (one component of the primary outcome)

    Time frame: from the postoperative day 1 until postoperative day 7 for a total of 7 days

    Renal complications in this study refers to acute Kidney Injury stages II and III diagnosed using the Kidney Disease Improving Global Guidelines (KDIGO).

  9. Infectious complications (one component of the primary outcome)

    Time frame: from postoperative day 1 until postoperative day 30 for a total of 30 days

    Infectious complications include the following:

    • Surgical site infection (deep surgical site):
    • Surgical site infection (organ/space)
    • Pneumonia
    • Laboratory confirmed bloodstream infection
    • Infection, source uncertain
    • Sepsis Sepsis will be diagnosed per the Third International Consensus Definitions.38,39 The Task Force defines sepsis as a "life-threatening organ dysfunction due to a dysregulated host response to infection." Clinical diagnosis of organ dysfunction requires a two-point increase in the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score, starting the day after surgery and continuing throughout hospitalization as shown below (adopted from Singer38).

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Tianjin Chest Hospital

Registry information

Official study title

Multisite Tissue Oxygenation Guided Perioperative Care to Reduce Composite Complications in Cardiac Surgical Patients: the BOTTOMLINE-CS Trial

Acronym: BOTTOMLINECS

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
May 21, 2021
Registry last updated
Mar 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.